
Edward Anders, Who Duped Nazis and Illuminated the Cosmos, Dies at 98
Edward Anders, a cosmochemist who unraveled mysteries about the solar system and the wildfires that helped wipe out the dinosaurs — and who then, in retirement, uncovered the identities of thousands of Jews from his hometown who were killed in the Holocaust — died on June 1 in San Mateo, Calif. He was 98.
His death, in an assisted living facility, was confirmed by his son, George.
Professor Anders emigrated to the United States in 1949, a few months after being called to testify at the Nuremberg trials about Nazi brutality in Liepaja, Latvia, in 1941 — events that he and his mother survived after she tricked soldiers into believing that she was of Aryan descent. His father wasn't as fortunate.
Settling in New York City, Edward enrolled at Columbia University and studied chemistry. One day, his professor — a curator at the American Museum of Natural History — brought a handful of meteorite rocks to pass around in class.
'I found them tremendously exciting,' Professor Anders said in a 2001 interview with the journal Meteoritics & Planetary Science. 'I would even use the word romantic. Here were samples from far beyond the Earth's orbit, older than any rock on Earth, and you can get your hands on them, and even do respectable research on them.'
Professor Anders's research turned out to be more than merely respectable. At the University of Chicago, his academic home for more than 30 years beginning in 1955, he conducted a series of groundbreaking studies into the early history of the solar system.
He demonstrated that meteorites were fragments from asteroids and not, as was believed at the time, debris from the moon or comets. He quantified the elements of the solar system in a journal article that has been cited more than 14,000 times. And he uncovered evidence of the global wildfires that helped lead to the dinosaurs' extinction.
Want all of The Times? Subscribe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Parents, You're Focusing on the Wrong Part of Your Kid's Screen Use
When it comes to monitoring kids and technology, parents are all doing the best we can. Especially in the summertime when rules fly out the window. However, a new study found that parents may actually be worried about the wrong thing when it comes to kids and screens. A study published June 18 in JAMA, a journal of the American Medical Association, found that the amount of time kids spent on social media, mobile phones, and video games wasn't linked to more internalized symptoms of mental health issues like anxiety and depression. Surprisingly, it also wasn't associated with externalized symptoms of mental health problems like rule breaking, aggression, suicidal behaviors, or suicidal ideation. This sounds good right? The problem is, researchers found that screen addiction was linked to both internal and external symptoms of mental health problems. More from SheKnows PopSockets Partnered With This Celeb-Loved Jewelry Brand to Drop Beach-Chic Limited-Edition Accessories There is a difference; a subtle distinction with big consequences. Yunyu Xiao, lead study author and an assistant professor in the department of population health sciences and department of psychiatry at Weill Cornell Medical College in New York, explained addiction as 'excessive use' that interferes with home responsibilities, schoolwork or other activities, per CNN. 'They find a craving for it and cannot stop using it,' he explained. The study found one in two of the young people in the study were on a 'high trajectory of addictive use' for mobile phones, while over 40 percent were on the same path for video games. For the kids with high or increasing use of social media and mobile phones, they were two to three times more likely to engage in suicidal behavior and suicidal ideations than kids on the lower trajectory. These kids also had increased risk of symptoms of mental health problems, with a high use of video games associated with a greater risk of symptoms of mental health problems, suicidal behaviors, and suicidal ideation. It's absolutely heartbreaking! And teens know they need help. In Feb. 2025, SheKnows spoke with teens in New York City about their phone use, and the results were concerning. One 16-year-old named Annabella told us that she spends 12 hours on her phone. 'My friends are on it [their phones], I feel like I couldn't get off it or certain apps, I don't know — I'm just, like, addicted,' Annabella admitted. The Anxious Generation author Jonathan Haidt recommends not giving your child a phone until high school, not allowing social media until 16, and encouraging real-world independence and risk-taking in kids. Ariana Hoet, Ph.D., executive clinical director of children's mental health organization On Our Sleeves, previously told SheKnows that she recommends designated screen-free times every day: during dinner, for example, and powering phones down a couple of hours before bedtime. You should also talk about screens as a family. 'You can talk about what social media platforms you're going to use. Who do you follow? What do you post? And then most importantly, when are the screen-free times? What are other activities you're doing? Who do you go to if you're worried about something?' Dr. Hoet told us. 'You also need to establish the consequences: what happens if these rules are broken?' Dr. Becky Kennedy, psychologist, author, and mom of three previously told SheKnows that screen time isn't inherently bad for kids. It all depends on what the screen time is being used for and if your kids have a healthy balance. She suggests parents define screen time boundaries in advance, encourage kids to learn on their screen before playing, and anticipate the meltdowns around screen time by setting firm boundaries about when to put it up at the end of the day. 'To me, if you're a parent who's just struggling with screen time with your kid, you're probably doing it right. It's a tool we need to use,' she told us. 'It's something I don't think parents need to feel guilty about. It's just something parents need to have a level of mindfulness about relative to making sure we're setting up our home today for success — but that we're also setting up our kids for success long-term.' Look out for these signs that your child might be addicted to cell phones or video games, per the Mayo Clinic: Intense urges for screen time or video games that block out other thoughts. Cutting back on social or recreational activities because of preference for screen time or video games. Feeling irritable, anxiety, or anger when forced to stop playing, even for brief periods of time. Lying to others about the extent of their use. Needing more screen time over time to get the same level of enjoyment. Neglecting their appearance, including lack of interest in grooming or clothing. If you think your child is developing a phone or video game addiction, call their pediatrician and/or therapist for help managing their addiction in a screen-heavy of SheKnows Tween & Teen Slang 2025: A Definitive Guide to 'What the Hellyante' Your Kid Is Saying Right Now Celebrity Parents Who Are So Proud of Their LGBTQ Kids Recent Baby & Toddler Product Recalls Every Parent and Caregiver Should Know About
Yahoo
an hour ago
- Yahoo
Actio gains $66m to advance small molecule therapeutics pipeline
US-based Actio Biosciences has closed a Series B financing round, raising $66m to advance the genetics-driven small molecule therapeutics pipeline aimed at rare and common diseases. The funding will primarily be used to propel the development of the company's lead oral programmes, ABS-1230 and ABS-0871. The round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management. Other participants were current investors Canaan, Euclidean Capital and Droia Ventures. ABS-1230 is a selective potassium channel subfamily T member 1 (KCNT1) inhibitor designed to address KCNT1-related epilepsy, a severe paediatric epileptic encephalopathy. The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025. The company then plans to expand into a Phase Ib proof-of-concept trial in patients with KCNT1-related epilepsy in early 2026. The US Food and Drug Administration (FDA) has awarded ABS-1230 both orphan drug and rare paediatric designations. ABS-0871, another small molecule in Actio's pipeline, inhibits transient receptor potential vanilloid 4 (TRPV4) and is being developed for the treatment of the rare inherited neurological disorder, Charcot-Marie-Tooth disease type 2C (CMT2C). Actio is progressing this therapy through the healthy volunteer phase of a Phase I trial and aims to move into a Phase Ib trial in individuals with TRPV4+ CMT2C in 2026. The US regulator has granted orphan drug, fast track and rare paediatric drug designations to the therapy. Actio Biosciences CEO and co-founder David Goldstein stated: 'We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. 'ABS-1230 and ABS-0871 have the potential to be transformative disease-modifying therapies in their respective rare indications, and growing evidence supports expansion into broader indications. This new funding from industry-leading investors speaks to the value of our approach and provides us with important resources to continue advancing our programmes.' "Actio gains $66m to advance small molecule therapeutics pipeline" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Is Increased Focus on Hypersonic Tech Opening New Doors for Rocket Lab?
In recent years, the rapid development and adoption of hypersonic technology across industries, from aerospace and defense to space exploration, have opened new growth avenues for Rocket Lab USA RKLB, a key player in hypersonic testing with its HASTE launch system. With commercial firms and government agencies ramping up investments in advanced hypersonic systems to bolster space access and national security, RKLB remains well-positioned to capitalize on this accelerating technological shift. Notably, Rocket Lab's HAEST (Hypersonic accelerator suborbital test electron) is a suborbital testbed launch vehicle that provides reliable, high-cadence flight test opportunities needed to boost hypersonic and suborbital system technology development. In April 2025, Rocket Lab secured a contract from Kratos Defense to conduct a full-scale hypersonic test flight for the U.S. Department of Defense. Additionally, RKLB's HASTE platform has been included in two major defense frameworks — the $46 billion Enterprise-Wide Agile Acquisition Contract with the U.S. Air Force and the UK Ministry of Defence's £1 billion ($1.3 billion) Hypersonic Technologies & Capability Development Framework. These programs allow Rocket Lab to compete for launch and engineering services in advancing hypersonic technologies. The inclusion across both U.S. and UK initiatives underscores the growing demand for HASTE in defense testing and is likely to significantly boost Rocket Lab's future revenue stream. While HASTE has not yet won any purely commercial contract, its demonstrated reliability and cadence in the defense sector may soon open doors to non-defense payload opportunities. As increased investment in hypersonic technology has become a global trend lately, with nations like the United States, the United Kingdom, and China significantly boosting funding for research and development in this tech, other stocks like Lockheed Martin LMT and RTX Corp. RTX are also indulging in advanced hypersonic technology developments. Notably, Lockheed Martin has been developing highly advanced hypersonic technology for the past 60 years. To this end, the company is currently working in partnership with DARPA, the U.S. Air Force, the U.S. Army, and the U.S. Navy to transition hypersonic concepts to operational reality. LMT's Conventional Prompt Strike is a hypersonic boost-glide missile currently under development, which boasts the capability to provide longer range, shorter flight times, and high survivability against enemy defenses. On the other hand, RTX is working across its business and domains to move advanced hypersonic capabilities from creation to testing and into the hands of warfighters at top speed. RTX is currently involved in the design of the Hypersonic Attack Cruise Missile, which leverages Northrop Grumman's scramjet propulsion to travel at more than five times the speed of sound and cover vast distances in minutes. The U.S. Air Force currently expects this missile to be operational by fiscal 2027. Shares of RKLB have surged 467.2% in the past year compared with the industry's 40.9% growth. Image Source: Zacks Investment Research The company's shares are trading at a premium on a relative basis, with its forward 12-month Price/Sales being 17.85X compared with its industry's average of 9.65X. Image Source: Zacks Investment Research The Zacks Consensus Estimate for RKLB's 2025 and 2026 earnings has improved over the past 60 days. Image Source: Zacks Investment Research RKLB currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report RTX Corporation (RTX) : Free Stock Analysis Report Rocket Lab Corporation (RKLB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio